Document Detail


Pharmacokinetics of cefotaxime in neonates.
MedLine Citation:
PMID:  6330019     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of gestational age on the pharmacokinetics of cefotaxime and its desacetyl metabolite during the first days of life was investigated in a group of four full-term infants and 12 preterm infants of less than 35 weeks gestation. Half of the preterm infants had received betamethasone, a drug known to facilitate hepatic microsomal drug metabolism, whilst the others had not. No significant differences in the pharmacokinetics of cefotaxime were observed between the various groups, with elimination half-life (T 1/2 beta) of cefotaxime ranging from 4.04 +/- 1.52 to 4.56 +/- 1.31 h. The desacetyl metabolite of cefotaxime was present in all post-dose serum samples, irrespective of the gestational age of the baby. Its formation was apparently unaffected by prior exposure to betamethasone. The elimination half-life of cefotaxime is significantly longer in newborn infants than in older children or adults, this increase probably results from decreased renal excretion of the drug, rather than from immaturity in its metabolism. A dose of 50 mg/kg of cefotaxime given every 12 h is appropriate for infants of less than seven days old.
Authors:
J Baird-Lambert; P E Doyle; D Thomas; M Cvejic; N Buchanan
Related Documents :
1497999 - A reappraisal of the measurement of glomerular filtration rate in pre-term infants.
142069 - Biotin in man's nutrition and therapy -- a review.
6978779 - The diagnosis of 21-hydroxylase deficiency in a prematurely born infant on the basis of...
24299039 - Factors related to patterns of body mass index in early infancy: 18-month longitudinal ...
19752079 - Impact of changes in serum sodium levels on 2-year neurologic outcomes for very preterm...
2506939 - Urinary excretion of prostacyclin metabolites in infants born after maternal preeclamps...
10756499 - Effect of decreasing cesarean births on maternal age-, parity- and ethnicity-associated...
10968379 - Why do mexican americans give birth to few low-birth-weight infants?
25092199 - Implications for observant jewish families in the provision of mother's own and donor m...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  13     ISSN:  0305-7453     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  1984 May 
Date Detail:
Created Date:  1984-08-17     Completed Date:  1984-08-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  471-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aging
Betamethasone / pharmacology
Biotransformation
Cefotaxime / metabolism*
Creatinine / blood
Dealkylation
Female
Gestational Age
Humans
Infant, Newborn*
Infant, Premature
Kinetics
Male
Serum Albumin / metabolism
Chemical
Reg. No./Substance:
0/Serum Albumin; 378-44-9/Betamethasone; 60-27-5/Creatinine; 63527-52-6/Cefotaxime

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antimycotic activity of BAY N 7133 in animal experiments.
Next Document:  The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid.